Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

513
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
513
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
Dementia01:30

Dementia

131
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
131
Neural Regulation01:37

Neural Regulation

39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

One-Pot Tandem Construction of Isoindolinone Derivatives under Visible-Light Photoredox Catalysis.

ACS omega·2026
Same author

Lipid Metabolic Disorders: a Pivotal Driver in Type 2 Diabetes Mellitus Pathogenesis.

Current obesity reports·2026
Same author

Diagnosis and treatment of neurofibromatosis type 1 with malignant transformation and multiple gastrointestinal stromal tumors: a case report and literature review.

Frontiers in medicine·2026
Same author

Clinical characterization and developmental follow-up of a child with Sotos syndrome carrying a novel NSD1 variant.

BMC pediatrics·2026
Same author

Enhancing Early Prediction of Gestational Diabetes Mellitus Through Data Augmentation and Feature Guidance: Model Development and Validation Study.

JMIR medical informatics·2026
Same author

Sperm DNA Fragmentation Testing in the Era of Assisted Reproduction: Clinical Utility, Thresholds, and Management Strategies.

Archivos espanoles de urologia·2026

Related Experiment Video

Updated: Jul 15, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K

EAMNet: an Alzheimer's disease prediction model based on representation learning.

Haoliang Duan1,2, Huabin Wang1,2, Yonglin Chen1,2

  • 1Anhui Provincial International Joint Research Center for Advanced Technology in Medical Imaging, Anhui University, Hefei, People's Republic of China.

Physics in Medicine and Biology
|September 29, 2023
PubMed
Summary
This summary is machine-generated.

This study introduces the efficient adaptive multiscale network (EAMNet) for predicting Alzheimer's disease (AD) using brain PET scans. EAMNet achieves high accuracy in classifying AD, Mild Cognitive Impairment (MCI), and Normal Controls (NC).

Keywords:
Alzheimer’s disease (AD)attention mechanismbrain 18F-FDG PETfeature fusionrepresentation learning

More Related Videos

Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
06:44

Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)

Published on: January 10, 2025

529
Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.0K

Related Experiment Videos

Last Updated: Jul 15, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K
Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
06:44

Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)

Published on: January 10, 2025

529
Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.0K

Area of Science:

  • Neuroimaging
  • Artificial Intelligence
  • Medical Diagnostics

Background:

  • 18F-FDG PET scans assess brain lesion metabolism, crucial for predicting Alzheimer's disease (AD).
  • Extracting relevant features and managing noise in PET images are significant challenges for accurate AD prediction.
  • Existing methods struggle with the complexity of PET image analysis for early disease detection.

Purpose of the Study:

  • To develop an innovative deep learning model, the efficient adaptive multiscale network (EAMNet), for predicting Alzheimer's disease (AD) using PET image slices.
  • To enhance feature extraction and noise compensation in PET imaging for improved diagnostic accuracy.
  • To enable earlier intervention and treatment planning for patients at risk of AD.

Main Methods:

  • Implemented an efficient convolutional strategy to optimize the receptive field and reduce computational complexity in PET image analysis.
  • Introduced a channel attention module for adaptive weight allocation, mitigating the impact of spatial noise on classification.
  • Utilized skip connections to effectively merge multi-scale lesion information, aligning with clinical relevance.

Main Results:

  • The EAMNet model demonstrated high classification performance on the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset.
  • Achieved accuracy rates of 97.66% (AD vs. NC), 96.32% (AD vs. MCI), 95.23% (MCI vs. NC), and 95.68% (AD vs. MCI vs. NC).
  • Visual analysis confirmed that the network's focus aligns with regions of interest identified by clinical experts.

Conclusions:

  • The proposed EAMNet significantly advances the accurate prediction and classification of Alzheimer's disease using18F-FDG PET imaging.
  • EAMNet outperforms existing state-of-the-art algorithms in AD classification tasks.
  • The developed method offers a promising tool for early diagnosis and patient stratification in Alzheimer's disease research.